# Role of Intravenous Versus Home Oral Antibiotics in Perforated Appendicitis

> **NCT02724410** · NA · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 82 (actual)

## Conditions studied

- Perforated Appendicitis

## Interventions

- **DRUG:** home intravenous ertapenem
- **DRUG:** home oral amoxicillin-clavulanate
- **DEVICE:** peripheral inserted central Catheter

## Key facts

- **NCT ID:** NCT02724410
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02724410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02724410, "Role of Intravenous Versus Home Oral Antibiotics in Perforated Appendicitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02724410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*